StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report sent to investors on Monday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

NYSE AMPE opened at $0.00 on Monday. The stock has a market capitalization of $2,964.00, a P/E ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $2.91. The firm has a 50-day moving average price of $0.01 and a 200 day moving average price of $0.05.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.